Table 2.
Biochemical indices measure at baseline, median (range), mg/dL.
| Danshen group (n = 63) | Placebo group (n = 63) | P values | |
|---|---|---|---|
| Lipid profile | |||
| LDL cholesterol | 118 (95–151) | 123 (94–154) | 0.875 |
| HDL cholesterol | 52 (43–64) | 54 (46–67) | 0.436 |
| Total cholesterol | 197 (178–239) | 191 (172–243) | 0.527 |
| Triglycerides | 117 (85–168) | 121 (84–171) | 0.329 |
| Apolipoprotein A | 93 (83–126) | 94 (85–128) | 0.811 |
| Apolipoprotein B | 71 (62–104) | 73 (65–99) | 0.743 |
| Apolipoprotein E | 6.9 (5.2–8.6) | 7.2 (5.3–8.5) | 0.632 |
| Lipoprotein (a) | 30 (20–45) | 33 (24–41) | 0.237 |
| Liver function | |||
| Gamma-glutamyl transpeptidase (IU/dL) | 2.8 (2.1–5.3) | 3.0 (2.5–5.1) | 0.165 |
| Total bilirubin | 0.5 (0.3–0.6) | 0.6 (0.4–0.8) | 0.175 |
| Indirect bilirubin | 0.4 (0.3–0.6) | 0.5 (0.3–0.5) | 0.268 |
| Direct bilirubin | 0.4 (0.2–0.5) | 0.3 (0.2–0.4) | 0.377 |
| Renal function | |||
| Uric acid | 5.1 (4.5–6.9) | 5.5 (4.1–6.4) | 0.264 |
| Risk factor of heart disease | |||
| Homocysteine | 22 (19–40) | 23 (21–42) | 0.459 |